Placebo-controlled study

Aug 02, 2018

Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION, Advances Phase 2 Study in Alzheimer's Disease in Canada

Aug 01, 2018

First Patient Enrolled In Biohaven's Phase 2/3 Mild-To-Moderate Alzheimer's Clinical Trial

Jul 03, 2018

Get Ready for the Summer With Astaxanthin From Algatech

Jun 27, 2018

AHS 2018: Lilly Highlights Positive Phase 3 Results from the Largest Controlled Preventive Trial in Episodic Cluster Headache

Jun 26, 2018

Breakthrough Randomized Controlled Trial Demonstrating TWO2 Efficacy in Healing Diabetic Foot Ulcers Unveiled at the American Diabetes Association 78th Scientific Sessions Conference

Jun 23, 2018

Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial

Apr 05, 2018

Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018

Nov 22, 2017

Khondrion Presents Phase II KHENERGY Trial Data

Nov 16, 2017

Khondrion Will Present First Results of KHENERGY Study